Regular Article
Bacteraemia due to Stenotrophomonas maltophilia: An Analysis of 45 Episodes

https://doi.org/10.1053/jinf.2002.0978Get rights and content

Abstract

Objective: Stenotrophomonas maltophilia is an important nosocomial pathogen and a therapeutic challenge. A ten-year review of episodes of bacteraemia due to S. maltophilia was undertaken in light of reports of an increasing frequency of infection.

Methods: A retrospective analysis of bloodstream infections due toS. maltophilia at a tertiary care hospital in Melbourne, Australia. Cases were identified via microbiology laboratory reports, and relevant clinical data were collected from the medical record of each patient.

Results: Eighty per cent of these 45 episodes were nosocomial. The most common characteristics in cases of bacteraemia were the presence of an indwelling central venous catheter (CVC) (38/45, 84%) and previous antibiotic therapy (33/45, 73%). There were 8 deaths (8/44, 18%) within 7 days of bacteraemia. A significant correlation was found between deaths and a failure to remove the CVC (P=0.01) or treat with appropriate antimicrobials (P=0.01). Antibiotic susceptibility testing revealed that isolates were most sensitive to sulphamethoxazole (80%), chloramphenicol (75.5%) and ceftazidime (64.5%).

Conclusions: S. maltophilia is an important pathogen especially in the highly compromised host. Isolation of this organism from a blood culture should prompt a careful review of the patient with particular emphasis on removal of indwelling CVCs and commencement of appropriate antibiotic therapy.

References (23)

  • JC Franklin

    Assessment of antibiotic-sensitive, intermediate or resistant status of bacteria by agar dilution

    Med Lab Sci

    (1988)
  • Cited by (138)

    • In which cases of pneumonia should we consider treatments for Stenotrophomonas maltophilia?

      2021, Journal of Hospital Infection
      Citation Excerpt :

      This means that the immune status of the host is a distinguishing factor that will lead to either infection and/or colonization. It has long been reported that S. maltophilia infections occur in people with poor immune status [1,19,21–25], and underlying diseases and steroids are heavily involved in immunosuppression. Pre-administration of an anticancer drug may be associated with immunosuppression.

    • Diversity of L1/L2 genes and molecular epidemiology of high-level carbapenem resistance Stenotrophomonas maltophilia isolates from animal production environment in China

      2020, Infection, Genetics and Evolution
      Citation Excerpt :

      The L1 structure includes a coordinating Zn2+ involved in the formation of a metal acceptor bond with the lactam oxygen and the carboxyl oxygen of antibiotics. Even though S. maltophilia is not a highly virulent pathogen, its associated crude mortality rates range from 14 to 69% in bacteremic patients (Adegoke et al., 2017; Alessandra Micozzi et al., 2000; Brooke, 2012; Cho et al., 2015; Friedman et al., 2002). This is most likely the result of its ability to colonize respiratory-tract epithelial cells and generate biofilms on medical device surfaces and this is reflected in its ability to cause nosocomial infections.

    • Risk factors for death from Stenotrophomonas maltophilia bacteremia

      2018, Journal of Infection and Chemotherapy
      Citation Excerpt :

      Some potential risk factors were not included due to lack of sepsis-related scoring data such as SOFA score or APACHE II score. Also, the study duration is shorter than for some other reports [7,20,21]. Continuing evaluation of trends in death by nosocomial S. maltophilia bacteremia and larger prospective studies with greater patient numbers are warranted.

    View all citing articles on Scopus

    Please address all correspondence to: N. D. Friedman, Infectious Diseases Fellow, Division of Infectious Diseases and International Health, Box 3824, Duke University Medical Center, Durham, NC 27710, USA. Tel.: +9196842660 Fax: +919–6817945; E-mail address: [email protected] (N. D. Friedman).

    View full text